Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autoimmune and angiogenic biomarkers in autoimmune atherosclerosis.
Balogh E, Pusztai A, Hamar A, Végh E, Szamosi S, Kerekes G, McCormick J, Biniecka M, Szántó S, Szűcs G, Nagy Z, Fearon U, Veale DJ, Szekanecz Z. Balogh E, et al. Among authors: hamar a. Clin Immunol. 2019 Feb;199:47-51. doi: 10.1016/j.clim.2018.12.011. Epub 2018 Dec 10. Clin Immunol. 2019. PMID: 30543922 Review.
Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis.
Póliska S, Besenyei T, Végh E, Hamar A, Pusztai A, Váncsa A, Bodnár N, Szamosi S, Csumita M, Kerekes G, Szabó Z, Nagy Z, Szűcs G, Szántó S, Zahuczky G, Nagy L, Szekanecz Z. Póliska S, et al. Among authors: hamar a. Arthritis Res Ther. 2019 Apr 15;21(1):94. doi: 10.1186/s13075-019-1862-6. Arthritis Res Ther. 2019. PMID: 30987671 Free PMC article.
Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis.
Gulyás K, Horváth Á, Végh E, Pusztai A, Szentpétery Á, Pethö Z, Váncsa A, Bodnár N, Csomor P, Hamar A, Bodoki L, Bhattoa HP, Juhász B, Nagy Z, Hodosi K, Karosi T, FitzGerald O, Szücs G, Szekanecz Z, Szamosi S, Szántó S. Gulyás K, et al. Among authors: hamar a. Clin Rheumatol. 2020 Jan;39(1):167-175. doi: 10.1007/s10067-019-04771-3. Epub 2019 Sep 14. Clin Rheumatol. 2020. PMID: 31522318
Biosimilars vs originators: Are they the same?
Sarzi-Puttini P, Marotto D, Caporali R, Galeazzi M, Atzeni F, Hamar A, Soós B, Szekanecz Z. Sarzi-Puttini P, et al. Among authors: hamar a. Autoimmun Rev. 2019 Dec;18(12):102404. doi: 10.1016/j.autrev.2019.102404. Epub 2019 Oct 19. Autoimmun Rev. 2019. PMID: 31639517 Review.
Complex assessment of bone mineral density, fracture risk, vitamin D status, and bone metabolism in Hungarian systemic sclerosis patients.
Horváth Á, Végh E, Pusztai A, Pethő Z, Hamar A, Czókolyová M, Bhattoa HP, Nagy G, Juhász B, Hodosi K, Domján A, Szekanecz Z, Szücs G, Szamosi S. Horváth Á, et al. Among authors: hamar a. Arthritis Res Ther. 2019 Dec 10;21(1):274. doi: 10.1186/s13075-019-2072-y. Arthritis Res Ther. 2019. PMID: 31823821 Free PMC article.
EULAR definition of difficult-to-treat rheumatoid arthritis.
Nagy G, Roodenrijs NMT, Welsing PM, Kedves M, Hamar A, van der Goes MC, Kent A, Bakkers M, Blaas E, Senolt L, Szekanecz Z, Choy E, Dougados M, Jacobs JW, Geenen R, Bijlsma HW, Zink A, Aletaha D, Schoneveld L, van Riel P, Gutermann L, Prior Y, Nikiphorou E, Ferraccioli G, Schett G, Hyrich KL, Mueller-Ladner U, Buch MH, McInnes IB, van der Heijde D, van Laar JM. Nagy G, et al. Among authors: hamar a. Ann Rheum Dis. 2021 Jan;80(1):31-35. doi: 10.1136/annrheumdis-2020-217344. Epub 2020 Oct 1. Ann Rheum Dis. 2021. PMID: 33004335 Free PMC article.
Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α Therapy.
Pusztai A, Hamar A, Horváth Á, Gulyás K, Végh E, Bodnár N, Kerekes G, Czókolyová M, Szamosi S, Bodoki L, Hodosi K, Domján A, Nagy G, Szöllősi I, Lopez LR, Matsuura E, Prohászka Z, Szántó S, Nagy Z, Shoenfeld Y, Szekanecz Z, Szűcs G. Pusztai A, et al. Among authors: hamar a. J Rheumatol. 2021 Jun;48(6):821-828. doi: 10.3899/jrheum.200916. Epub 2020 Dec 15. J Rheumatol. 2021. PMID: 33323530
33 results